Amphastar Pharmaceuticals
AMPH
AMPH
133 hedge funds and large institutions have $471M invested in Amphastar Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 58 increasing their positions, 41 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 135 → 133 (-2)
96% less call options, than puts
Call options by funds: $21K | Put options by funds: $517K
Holders
133
Holding in Top 10
–
Calls
$21K
Puts
$517K
Top Buyers
| 1 | +$12.1M | |
| 2 | +$3.43M | |
| 3 | +$3.27M | |
| 4 |
Renaissance Technologies
New York
|
+$3.09M |
| 5 |
MSL
Mackay Shields LLC
New York
|
+$2.46M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$4.61M | |
| 3 | -$3.37M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.25M |
| 5 |
SAM
Sawgrass Asset Management
Ponte Vedra Beach,
Florida
|
-$1.3M |